MELI vs RTX: Which Is the Better Buy?

Side-by-side comparison of MercadoLibre, Inc. and RTX Corporation β€” fair value, conviction, valuation metrics, and QuantHub research signals. Updated 2026-05-04.
MercadoLibre, Inc. Β· Consumer Cyclical
$1,767.42
+41.4% upside to fair value
High Conviction Grade A
VS
RTX Corporation Β· Industrials
$172.90
-21.3% upside to fair value
Grade D
QuantHub Verdict
MELI has more upside to fair value (+41.4%). RTX trades at a lower forward P/E (32.1x). These are model outputs β€” not personalized investment advice. See all research β†’
Valuation & Fundamentals
Metric MELI RTX
Current Price $1,767.42 $172.90
Fair Value Estimate $2,500.00 $136.05
Upside to Fair Value +41.4% -21.3%
Market Cap $89.6B $232.8B
Forward P/E 35.0x 32.1x
EV / EBITDA 18.5x 19.2x
Price / Sales 3.1x 2.6x
Price / FCF 8.9x 27.9x
Revenue Growth YoY +39.1% +8.7%
Gross Margin 44.5% 20.2%
Operating Margin 11.1% 10.4%
Return on Equity 33.7% 11.2%
Dividend Yield 0% 0%
FCF Yield 12.1% 3.59%
Analyst Consensus Strong Buy Buy
Investment Thesis
MELI β€” MercadoLibre, Inc.
MercadoLibre is the dominant e-commerce and fintech ecosystem across Latin America, operating the largest marketplace and digital payments platform in a region with 670M+ people where e-commerce penetration is still under 15%. Revenue grew 39% to $28.9B in FY2025 with $10.8B in free cash flow β€” a 12% FCF yield at current prices. The company is trading at its 5-year P/S minimum (3.1x) and P/FCF mi…
RTX β€” RTX Corporation
RTX Corporation is a leading aerospace and defense company with a diversified portfolio spanning Pratt & Whitney jet engines, Collins Aerospace avionics, and Raytheon Intelligence & Space defense systems. The company benefits from a strong competitive moat supported by a $271 billion backlog and multi-year contracts, driving consistent revenue growth of 10% in 2025 and 9% in Q1 2026. Earnings gro…
Accumulation Zones
Metric MELI RTX
Zone Low $1,875.00 $102.04
Zone High $2,125.00 $115.64
In Buy Zone? Yes No
← MELI Research    RTX Research β†’    All Research